Persons with
sleep disordered breathing (SDB) may, or may not, recognize that they have symptoms of SDB, and / or that they may be at-risk of, or suffering certain
health problems associated with SDB, including death. The disclosed Energy Conversion Monitor (ECM) sensor, when embodied, for example, in a wearable upper-armband format, has been demonstrated to be more sensitive and responsive than
pulse oximetry monitoring of blood
oxygen saturation as an indication of
hypoxic stress induced by SDB, and is compatible with: (1) inclusion in sleep laboratory polysomnograph (PSG) testing
instrumentation, (2) home-based diagnostic testing for SDB, (3) control of home-use
airway therapy devices, (4) continuous remote surveillance and refinement of
airway therapy, and (5) spot-check and continuous surveillance of
sleep quality in the general
population. The disclosed ECM also provides new measurements of physiologic stress during and following exercise. When applied during initial care of premature newborn infants, it offers improved therapeutic guidance during their transition from their limited
in utero oxygen supply conditions, to the increased
oxygen availability from
breathing air. When applied during
resuscitation of persons suffering from hypoxia and during reperfusion of ischemic tissue, such as during treatment of
ischemic stroke, or
ischemic heart attack, the ECM sensor can provide objective guidance regarding the safe and effective resupply of oxygen to the hypoxia-adapted tissue to help reduce or prevent microvascular
occlusion and cellular injury. As a continuously worn physiologic surveillance monitor, the ECM offers the potential of
early detection of
sepsis. For the elderly and infirm, the ECM offers a convenient and comfortable means of continuously assessing variations in status while awake and asleep.